Rockwell Medical will spend $125 million to take control of Vantive’s in-center hemodialysis operations across 35 countries and territories, a deal that reshapes the company’s footprint in kidney care.
The acquisition, finalized through an Equity and Asset Purchase Agreement, covers Vantive’s hemodialysis business in markets including the United States. Financing relies heavily on seller support, with $100 million arriving through term loans provided by Vantive and another $25 million coming from a convertible note. Earnout provisions could push the total higher by up to $45 million, contingent on performance targets.
**How the deal works**
Rockwell Medical signed the agreement effective November 2, 2026. The arrangement remains active until closing conditions wrap up and any deferred transfers finish. Regulatory approvals and standard closing requirements still stand between signing and completion.
The base purchase price comes with adjustment mechanisms that could shift the final figure. As a result, Rockwell Medical gains access to a broader hemodialysis product portfolio and service network, strengthening its position in the in-center dialysis market where treatment volumes remain steady but competitive pressure continues to build.
**Strategic expansion**
The acquisition signals Rockwell Medical’s push beyond its existing product lines into a more comprehensive dialysis service model. By absorbing Vantive’s in-center business, the company picks up established relationships with dialysis facilities and patients across dozens of jurisdictions.
Meanwhile, Vantive’s decision to offload this segment suggests a strategic realignment of its own healthcare portfolio. The seller-backed financing structure reduces Rockwell Medical’s need for outside capital, though it also ties part of the company’s future cash flows to debt repayment.
The deal’s completion hinges on regulators in multiple markets. Once those hurdles clear, Rockwell Medical will begin integrating operations and pursuing the earnout provisions that could add millions more to the final price tag.
